Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy
Jinfeng Cao(Leiden University Medical Center), Robert M. Verdijk(Erasmus MC Cancer Institute)
Cited by 61
Related Papers
Prevalence and Implications of<i>TERT</i>Promoter Mutation in Uveal and Conjunctival Melanoma and in Benign and Premalignant Conjunctival Melanocytic Lesions
|Investigative Ophthalmology & Visual Science|2014|91
HLA Class I Antigen Expression in Conjunctival Melanoma Is Not Associated With PD-L1/PD-1 Status
|Investigative Ophthalmology & Visual Science|2018|12